共 2 条
- [1] E2100: A Phase III Trial of Paclitaxel Versus Paclitaxel/Bevacizumab for Metastatic Breast Cancer[J] . Kathy D. Miller.Clinical Breast Cancer . 2003 (6)
- [2] Phase HI,multicenter,dou-ble-blind.randomized study of letrozole,an aromatase inhibitor,for advanced breast cancer versus megestrol acetate. BuzdarA,Douma J,DavidsonN,et al. Journal of Clinical Oncology . 2001